European shares edge lower as US-Iran talks stall; corporate earnings on tap

European shares fell 0.3% to 606.94 as investors weighed stalled U.S.-Iran negotiations and the broader market impact of the war, which has pushed oil prices higher and kept the Strait of Hormuz closed. BP rose 2.3% after first-quarter profit beat expectations, while Novartis fell 4.5% on weaker-than-expected quarterly core operating profit and sales. Norwegian Air Shuttle gained about 4% after a smaller-than-expected operating loss helped by currency, fuel hedges, and lower ETS costs.

Analysis

The market is still pricing this as a binary geopolitics headline, but the second-order effect is a regime shift in cross-asset dispersion: Europe is where input-cost shock, weaker balance sheets, and lower pricing power collide fastest. That makes the region more vulnerable than U.S. equities to a prolonged energy shock because margins get hit before revenue can reprice, especially in airlines, chemicals, consumer discretionary, and industrials. The relative underperformance of energy-dependent European equities is likely to persist until investors gain clarity on shipping and insurance premiums, not just on crude direction.

For Novartis, the miss is less about one quarter and more about the market recalibrating which pharma names deserve a premium multiple in a higher-rate, higher-cost-of-capital environment. Large-cap defensives often get treated as insulated, but if top-line growth is slowing while pipeline visibility stays unchanged, the valuation floor compresses quickly. That argues for more downside in the next several weeks if peers continue to report mixed execution, because the market will punish “quality without acceleration.”

The cleaner trade is not outright long energy here, but long volatility across Europe with a tilt toward sectors most exposed to jet fuel, freight, and imported industrial inputs. If Hormuz remains constrained for another 2-6 weeks, you should see a lagged earnings downgrade cycle in transport and manufacturing that is larger than the immediate move in spot commodities. Conversely, any credible diplomatic thaw would unwind the inflation impulse faster than consensus expects, because positioning is already leaning defensively and the marginal buyer has become more macro-sensitive.

The consensus may be underestimating how quickly the trade becomes self-reinforcing through currencies: a stronger dollar and weaker European cyclicals can amplify the pain even if oil stabilizes. That creates a better relative-value setup in Europe than in the U.S., but only if you avoid chasing the first move in oil and instead express the view through earnings-sensitive equities and volatility structures.

Key Decisions for Investors

• Short NVS on a 2-4 week horizon against a basket of large-cap European healthcare defensives; target 5-7% downside if the market continues to reward growth acceleration over stability, with a tight stop if management guides back to re-acceleration.
• Buy Euro Stoxx 600 put spreads expiring in 1-2 months as a convex hedge on persistent energy disruption; payoff is strongest if crude remains elevated while earnings revisions start to roll over.
• Short European airlines and transport names versus long energy producers as a relative-value pair for the next 4-8 weeks; the trade should work even if oil consolidates, as fuel-cost pass-through lags are the bigger driver.
• Add a small long-vol position via broad Europe index options rather than outright equity shorts; best risk/reward if headlines remain noisy and realized volatility stays elevated into the next central bank cycle.
• If diplomatic progress emerges, cover cyclical Europe shorts quickly and rotate into beneficiaries of lower input costs, since the unwind in inflation expectations could be sharp over 3-5 trading sessions.